Field examiners play a crucial role in a workout by analyzing a company’s working capital to identify collateral shortfalls. During these unprecedented times, the need for early detection and intervention is crucial. While field examiners' primary focus is evaluating the collateral base, they...
There isn't much that you can control in these uncertain times. But you can take important steps to protect your company from financial destruction due to current business conditions. Cash is king, particularly during times of economic distress. But having cash in the bank does not mean that a...
As a streamlined alternative to bankruptcy or ABCs, a strategic UCC Article 9 short-sale of business assets can resolve and relaunch a business operation, predictably and efficiently, requiring only the consent of the senior creditor and defaulting borrower. Through a senior lender’s Article 9...
What would it look like if regulation came to the unregulated? Would that put an end to banks efficiently offloading their distress? Paycheck Protection Program (PPP) funding, other government bailout money, and private equity (PE) money...
What are the takeaways from recent litigation? How do minority lenders protect themselves? Does increased restructuring activity change the lender approach? These topics, and more, will be discussed with a panel of experts.
The next 1-3 years are going to be bumpy, with energy prices and high capital costs squeezing companies and causing a lot of problems. In this exciting session, you’ll hear from panelists who have experience in varying aspects of energy...
Among the many effects of the COVID-19 pandemic, shifts in consumer spending caused unprecedented volatility. Companies that were agile enough to pivot quickly seized the opportunities for growth in areas such as health and fitness, home...
Join an esteemed group of panelists on our signature Mega Trends panel as they discuss economic factors and geopolitical trends that will impact what sectors and assets are likely to become distressed in the coming year. Topics will...
Learn the ABCs of the biotech world, including restructuring in biotech. What is the market like for this industry, and where is the money going? Where does the FDA process fit in, and what are the unique considerations regarding the erosion of asset value? What...
